In a nutshell This study was a phase I clinical trial that tested the safety and efficacy of Dabrafenib in melanoma patients with brain metastases (melanoma that has spread to the brain). Results showed that the drug had manageable side effects and improved progression-free survival. Some background Metastatic melanoma means that the cancer has...
Read MorePhase I clinical trial for Dabrafenib in patients with brain metastases from melanoma
